• Elaprase 2 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  IDURSULFASE	2 mg

  ATC: A16A A16AB A16AB09

• Elvanse 30 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Lisdexamfetamine Dimesylate	30.0 mg

  ATC: N06B N06BA N06BA12

• Elvanse 50 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Lisdexamfetamine Dimesylate	50,0 mg

  ATC: N06B N06BA N06BA12

• Elvanse 70 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Lisdexamfetamine Dimesylate	70.0 mg

  ATC: N06B N06BA N06BA12

• Elvanse Adults 30 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Lisdexamfetamine Dimesylate	30 mg

  ATC: N06B N06BA N06BA12

• Elvanse Adults 50 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Lisdexamfetamine Dimesylate	50 mg

  ATC: N06B N06BA N06BA12

• Elvanse Adults 70 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Lisdexamfetamine Dimesylate	70 mg

  ATC: N06B N06BA N06BA12

• Equasym 20 mg modified-release hard capsules

  Form: capsules, hard modified-release

  Active substance	Dosage
  METHYLPHENIDATE HYDROCHLORIDE	20 mg

  ATC: N06B N06BA N06BA04

• Equasym 30 mg modified-release hard capsules

  Form: capsules, hard modified-release

  Active substance	Dosage
  METHYLPHENIDATE HYDROCHLORIDE	29,94 mg

  ATC: N06B N06BA N06BA04

• Equasym 40 mg modified-release hard capsules

  Form: capsules, hard modified-release

  Active substance	Dosage
  METHYLPHENIDATE HYDROCHLORIDE	40.0 mg

  ATC: N06B N06BA N06BA04

• Equasym 50 mg modified-release hard capsules

  Form: capsules, hard modified-release

  Active substance	Dosage
  METHYLPHENIDATE HYDROCHLORIDE	50.0 mg

  ATC: N06B N06BA N06BA04

• Firazyr 30 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  ICATIBANT	30 mg

  ATC: B06A B06AC B06AC02

• Fosrenol 1000 mg chewable tablets

  Form: tablets, chewable

  Active substance	Dosage
  LANTHANUM CARBONATE	1908,0 mg

  ATC: V03A V03AE V03AE03

• Fosrenol 1000 mg oral powder

  Form: powder, oral

  Active substance	Dosage
  LANTHANUM	1000 mg

  ATC: V03A V03AE V03AE03

• Fosrenol 500 mg chewable tablets

  Form: tablets, chewable

  Active substance	Dosage
  LANTHANUM CARBONATE	954,0 mg

  ATC: V03A V03AE V03AE03

• Fosrenol 750 mg chewable tablets

  Form: tablets, chewable

  Active substance	Dosage
  LANTHANUM CARBONATE	1431,0 mg

  ATC: V03A V03AE V03AE03

• Fosrenol 750 mg oral powder

  Form: powder, oral

  Active substance	Dosage
  LANTHANUM	750 mg

  ATC: V03A V03AE V03AE03

• Fruzaqla 1 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  FRUQUINTINIB	1 mg

  ATC: L01E L01EK L01EK04

• Fruzaqla 5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  FRUQUINTINIB	5 mg

  ATC: L01E L01EK L01EK04

• Intuniv 1 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	1,14 mg

  ATC: C02A C02AC C02AC02

• Intuniv 2 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	2,28 mg

  ATC: C02A C02AC C02AC02

• Intuniv 3 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	3,42 mg

  ATC: C02A C02AC C02AC02

• Intuniv 4 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	4,56 mg

  ATC: C02A C02AC C02AC02

• Livtencity 200 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  MARIBAVIR	200 mg

  ATC: J05A J05AX J05AX10

• Mezavant 1.200 mg prolonged-release gastro-resistant tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  MESALAZINE	1200 mg

  ATC: A07E A07EC A07EC02

• Replagal 1 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  AGALSIDASE ALFA	1 mg

  ATC: A16A A16AB A16AB03

• Resolor 1 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  PRUCALOPRIDE SUCCINATE	1 mg

  ATC: A06A A06AX A06AX05

• Resolor 2 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  PRUCALOPRIDE SUCCINATE	2 mg

  ATC: A06A A06AX A06AX05

• Revestive 5 mg powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  TEDUGLUTIDE	5 mg

  ATC: A16A A16AX A16AX08

• Takhzyro 150 mg solution for injection in pre-filled syringe

  Form: solution for injection

  Active substance	Dosage
  LANADELUMAB	150 mg

  ATC: B06A B06AC B06AC05

• Takhzyro 300 mg solution for injection in pre-filled syringe

  Form: solution for injection

  Active substance	Dosage
  LANADELUMAB	300 mg

  ATC: B06A B06AC B06AC05

• Vpriv 400 units powder for solution for infusion

  Form: powder for solution for infusion

  Active substance	Dosage
  VELAGLUCERASE ALFA	400 U

  ATC: A16A A16AB A16AB10

• Xagrid 0.5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  ANAGRELIDE HYDROCHLOROGENIDE	0,5 mg

  ATC: L01X L01XX L01XX35